Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Purified human PSA.|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7.6, with 1% BSA|
|Contains||<0.1% sodium azide|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:200|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
A suggested positive control is normal prostate or prostate carcinoma.
PSA is a chymotrypsin-like serine protease (kallikrein family) produced by the prostate epithelium, and abundant in seminal fluid. PSA can be detected in the sera of patients with prostatic carcinoma. It is predominantly complexed to a liver-derived serine protease inhibitor, alpha-1-antichymotrypsin (ACT). A higher proportion of serum PSA is complexed to ACT in prostate cancer than in benign prostate hyperplasia.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Presence of PSA auto-antibodies in men with prostate abnormalities (prostate cancer/benign prostatic hyperplasia/prostatitis).
PA1-38514 was used in ELISA and western blot to examine the sera of patients with prostate abnormalities for the presence of anti-prostate-specific antigen antibodies
|Lokant MT,Naz RK||Andrologia (47:328)||2015|
Antibodies to prostate-specific antigen in immunoinfertile women and men.
PA1-38514 was used in western blot to study the incidence of antibodies against prostate specific antigen in the sera of immunoinfertile men and women
|Naz RK,Butler TS||Journal of reproductive immunology (97:217)||2013|
Immunodevice for simultaneous detection of two relevant tumor markers based on separation of different microparticles by dielectrophoresis.
PA1-38514 was used in immunocytochemistry to develop a simultaneous detection method for tumor markers alpha-fetoprotein and prostate-specific antigen
|Ramón-Azcón J,Yasukawa T,Mizutani F||Biosensors & bioelectronics (28:443)||2011|
gamma-seminoprotein; kallikrein-3; kallikrein-related peptidase 3; P-30 antigen; Prostate Specific Antigen; semenogelase; seminin
APS; hK3; KLK2A1; KLK3; PSA